ClinicalTrials.gg
CompletedNCT07686276Updated Jul 7, 2026

Brief Psychological Intervention to Reduce Alcohol Consumption

An interventional study of Self-incentive and Plan in Health Behavior, sponsored by Lancaster University. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Lancaster University · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
228
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Health Behavior with a site in United Kingdom — 2 open to participants now, 2 under way, none of them phase 3. Health Behavior · United Kingdom.

Enrollment
9th of 27
228 · median 140
Started
2026
the only one that year
No phase
25 of 32
1 open now
Registered
32nd of 32
by date

Among the 32 studies in Health Behavior with a site in United Kingdom, this one is the 9th largest by enrollment of the 27 interventional ones that give a count, is the only one that started in 2026, is one of 25 with no phase, and was the 32nd registered.

Health Behavior

970 studies on the registry are indexed under Health Behavior; 166 are open to participants now.

Browse Health Behavior studies →

Open to participants now

2 of the 32 studies in Health Behavior with a site in United Kingdom are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 94 Health Behavior studies recruiting now, 39 (41%) set no upper age limit and 38 (40%) stop at 75 or younger; 25 take children under 18; 59 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Health Behavior with a site in United Kingdom, or all of them as a file.
02

Study summary

Continuous levels of hazardous alcohol consumption (i.e., 14 or more units per week) is one of the leading risk factors of ill health and early mortality, contributing to around 9,809 deaths a year in the UK. The aim of the present research is to test the effect of helping people to reward themselves when they have successfully reduced/abstained from their previous levels of alcohol consumption. Each participant will be randomly allocated to one of two conditions. The trial requires 128 participants to perform a fully powered statistical analysis. The two conditions include: (1) a control condition (asked to form a plan to reduce/abstain from alcohol consumption), or (2) a weekly self-incentivising condition (asked to reward themselves at the end of each week that they have successfully reduced/abstained their previous levels of alcohol consumption). The main outcome measure will be units of alcohol consumed/not consumed, which will be self-reported at 1-week and 1-month follow-up time points.

Read the detailed description

The research aims to test the role of self-incentivising implementation intentions for reductions/abstinence of alcohol consumption among people aged 18 and over, residing in the UK, and consuming 14 units of more of alcohol at the start of the study. The effectiveness of self-incentives has been successfully seen previously within health behaviour change, has not been tested in reduction/abstinence of alcohol consumption. Therefore, this research will build on what is known about the effectiveness of self-incentives used for increasing fruit and vegetable consumption, and smoking cessation.

This study is a randomised controlled trial with the between participants factor of condition which has two levels:

1. Control (plan) or 2. Weekly self-incentivising implementation intention.

The within participants' factor will be time which has three levels:

Baseline (T1) Follow-up (T2) (1-week following baseline) Follow-up (T3) (1-month following baseline)

An ethical concern is that participants in the control condition may struggle more to reduce/abstain from alcohol consumption as they will not have the additional benefits of being within an experimental condition which uses self-incentives to aid their attempt. A control condition is needed to monitor if changes to alcohol consumption is due to the use of self-incentives or another behaviour change technique.

The recruitment process will recruit participants to complete an online questionnaire (via Qualtrics), from Prolific. Prolific is an online recruitment platform, which allows screeners to be set (e.g., age, residency, consumption level) prior to contacting potential participants. Prolific then contacts the participants to which the screeners apply, and the participants can decide if they would like to take part. The researcher can then set restrictions to only allow completion of the follow-up questionnaires, based on those participants who completed the online questionnaire at baseline.

All participants who are able to provide informed consent, are over the age of 18 years old, resident in the UK (due to discrepancies in the safe recommended alcohol consumption rates across countries), are eligible to take part in the study. Unfortunately, the study does not cater for people who cannot understand English at the present time, although this will be monitored for amendments in future studies.

The participant information sheet included prior to the online questionnaire includes details about the study, costs and benefits of taking part in the study, and the right to consent and withdraw at any point throughout the study. There are no risks involved in taking part in the study. Participants are reimbursed via Prolific based on the expected time to complete each questionnaire (i.e., £3.55 per questionnaire completed, which equates to more than the current UK living wage). There is a minimal burden in time taken to complete the questionnaires, which should take no longer than 15 minutes per time point, though this time estimation is considered generous.

In terms of confidentiality, participants will not provide any identifier other than their Prolific ID. This ensures that no identifying information is available to the research team, but that the participant can be added to the screener for completion of the baseline questionnaires, and that all questionnaires (baseline, 1-week follow-up, and 1-month follow-up) can be matched.

There are no conflicts of interest. Participants are provided with contact details of the research team, should they like to contact for a summary of the results.

03

Conditions studied

  • Health Behavior

Browse trials for

Keywords

  • Behavioral: Self-incentive
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or over
  • Able to understand written English
  • Competent to provide
  • Residing in the UK
  • Regularly consuming 14 units of alcohol or more at baseline

Exclusion criteria

Exclusion Criteria:

  • Note aged 18 years old or over
  • Not able to understand written English
  • Not competent to provide
  • Not residing in the UK
  • Not regularly consuming 14 units of alcohol or more at baseline
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
228 participants (actual)

Study arms

  • Experimental
    Behavioural: Self-incentive

    Weekly self-incentivising

    Behavioral: Self-incentive

  • Active comparator
    Plan

    Control

    Behavioral: Plan

Interventions

  • BehavioralSelf-incentive

    Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption). Participants are then asked to specify a self-incentive on which they could implement at the end of each week which they have been successful.

  • BehavioralPlan

    Participants read a brief statement designed to encourage them to reduce/abstain from alcohol consumption (we would like you to plan to reduce/abstain your alcohol consumption). Participants are then asked to form their plan.

06

What researchers measure

Primary outcomes

  1. Alcohol consumption

    Total units of alcohol consumed in last week

    Time frame: Up to 1-month

Secondary outcomes

  1. Alcohol use disorders identification test (AUDIT)

    Changes in AUDIT scores

    Time frame: Up to 1- month

  2. Compliance to self-incentivise

    Whether participants allocated to the intervention self-incentives

    Time frame: Up to 1-month

  3. Frequency of self-incentivisation

    How frequently participants allocated to the intervention condition use self-incentives

    Time frame: Up to 1-month

  4. Self-incentives used

    What self-incentives are chosen by participants (monetary, BCT etc)

    Time frame: Up to 1-month

07

Study locations

1 site
  • Lancaster University
    Lancaster, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided — Data may be shared if this complies with ethical guidelines

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2026 to primary completion in Jun 2026, 1 month.

Of 569 non-industry interventional studies with no phase under Health Behavior, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's 1 month is below that.

Counting every sponsor, half of 587 studies reached it within 15 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2026
First posted
Jul 7, 2026
StartActual
May 20, 2026
Primary completionActual
Jun 21, 2026
CompletionActual
Jun 21, 2026
Last update
Jul 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07686276
Lead sponsor
Lancaster University
Responsible party
Emma Brown (Dr Emma Brown, Lancaster University) — Principal investigator
First posted
Jul 7, 2026
Start date
May 20, 2026
Primary completion
Jun 21, 2026
Completion
Jun 21, 2026
Last update
Jul 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion